A federal Indiana court’s decision to temporarily halt the 340B administrative dispute resolution process because of the Trump HHS’ unusual rulemaking procedures will have little near-term effect because the Biden administration has yet to fill the ADR panels, an industry lawyer said. But 340B Health said the order reinforces its belief that the Health Resources and Services Administration should directly stop drug makers’ contract pharmacy restrictions instead of punting the issue to dispute panels. "The decision reinforces our strong belief...